SUPN logo

Supernus Pharmaceuticals, Inc. (SUPN) Long term debt

Annual long term debt:

$27.38M-$5.81M(-17.51%)
December 31, 2024

Summary

  • As of today (September 16, 2025), SUPN annual long term debt is $27.38 million, with the most recent change of -$5.81 million (-17.51%) on December 31, 2024.
  • During the last 3 years, SUPN annual long term debt has fallen by -$393.17 million (-93.49%).
  • SUPN annual long term debt is now -93.54% below its all-time high of $423.98 million, reached on December 31, 2020.

Performance

SUPN Long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNbalance sheet metrics

Quarterly long term debt:

$24.38M-$1.99M(-7.53%)
June 30, 2025

Summary

  • As of today (September 16, 2025), SUPN quarterly long term debt is $24.38 million, with the most recent change of -$1.99 million (-7.53%) on June 30, 2025.
  • Over the past year, SUPN quarterly long term debt has dropped by -$5.91 million (-19.51%).
  • SUPN quarterly long term debt is now -94.51% below its all-time high of $444.06 million, reached on March 31, 2022.

Performance

SUPN Quarterly long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNbalance sheet metrics

Long term debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

SUPN Long term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-17.5%-19.5%
3 y3 years-93.5%-36.6%
5 y5 years-93.1%-94.2%

SUPN Long term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-93.5%at low-36.6%at low
5 y5-year-93.5%at low-94.5%at low
alltimeall time-93.5%>+9999.0%-94.5%+333.3%

SUPN Long term debt History

DateAnnualQuarterly
Jun 2025
-
$24.38M(-7.5%)
Mar 2025
-
$26.37M(-3.7%)
Dec 2024
$27.38M(-17.5%)
$27.38M(-5.3%)
Sep 2024
-
$28.93M(-4.5%)
Jun 2024
-
$30.29M(-8.2%)
Mar 2024
-
$32.99M(-0.6%)
Dec 2023
$33.20M(-7.8%)
$33.20M(-1.9%)
Sep 2023
-
$33.84M(-1.0%)
Jun 2023
-
$34.18M(-6.4%)
Mar 2023
-
$36.51M(+1.4%)
Dec 2022
$36.00M(-91.4%)
$36.00M(-0.1%)
Sep 2022
-
$36.03M(-6.3%)
Jun 2022
-
$38.44M(-91.3%)
Mar 2022
-
$444.06M(+5.6%)
Dec 2021
$420.55M(-0.8%)
$420.55M(+0.1%)
Sep 2021
-
$420.19M(+0.9%)
Jun 2021
-
$416.55M(-1.9%)
Mar 2021
-
$424.83M(+0.2%)
Dec 2020
$423.98M(+7.4%)
$423.98M(+0.6%)
Sep 2020
-
$421.29M(+0.7%)
Jun 2020
-
$418.29M(+5.0%)
Mar 2020
-
$398.40M(+0.9%)
Dec 2019
$394.86M(+12.2%)
$394.86M(+1.6%)
Sep 2019
-
$388.72M(+0.7%)
Jun 2019
-
$385.85M(+0.7%)
Mar 2019
-
$383.09M(+8.8%)
Dec 2018
$352.04M(+1481.6%)
$352.04M(+0.9%)
Sep 2018
-
$348.97M(+0.9%)
Jun 2018
-
$345.79M(+0.9%)
Mar 2018
-
$342.60M(+1439.2%)
DateAnnualQuarterly
Dec 2017
$22.26M(-29.2%)
$22.26M(-2.0%)
Sep 2017
-
$22.70M(-11.5%)
Jun 2017
-
$25.66M(-11.1%)
Mar 2017
-
$28.86M(-8.2%)
Dec 2016
$31.45M(-15.3%)
$31.45M(+444.9%)
Sep 2016
-
$5.77M(+1.3%)
Jun 2016
-
$5.70M(+1.3%)
Mar 2016
-
$5.63M(-84.8%)
Dec 2015
$37.12M(+37.7%)
$37.12M(+360.0%)
Sep 2015
-
$8.07M(-7.9%)
Jun 2015
-
$8.76M(-25.2%)
Mar 2015
-
$11.71M(-56.6%)
Dec 2014
$26.95M(-21.6%)
$26.95M(+1.7%)
Sep 2014
-
$26.50M(-7.6%)
Jun 2014
-
$28.67M(+1.1%)
Mar 2014
-
$28.36M(-17.5%)
Dec 2013
$34.39M(+210.2%)
$34.39M(-42.8%)
Sep 2013
-
$60.17M(+1.8%)
Jun 2013
-
$59.10M(+641.1%)
Mar 2013
-
$7.97M(-28.1%)
Dec 2012
$11.09M(-51.2%)
$11.09M(-21.5%)
Sep 2012
-
$14.12M(-17.3%)
Jun 2012
-
$17.06M(-14.4%)
Mar 2012
-
$19.93M(-12.3%)
Dec 2011
$22.71M(>+9900.0%)
$22.71M(-73.6%)
Sep 2011
-
$86.01M(+14.7%)
Dec 2010
$0.00(-100.0%)
-
Sep 2010
-
$75.00M(0.0%)
Dec 2009
$75.00M(0.0%)
$75.00M
Dec 2008
$75.00M
-

FAQ

  • What is Supernus Pharmaceuticals, Inc. annual long term debt?
  • What is the all time high annual long term debt for Supernus Pharmaceuticals, Inc.?
  • What is Supernus Pharmaceuticals, Inc. annual long term debt year-on-year change?
  • What is Supernus Pharmaceuticals, Inc. quarterly long term debt?
  • What is the all time high quarterly long term debt for Supernus Pharmaceuticals, Inc.?
  • What is Supernus Pharmaceuticals, Inc. quarterly long term debt year-on-year change?

What is Supernus Pharmaceuticals, Inc. annual long term debt?

The current annual long term debt of SUPN is $27.38M

What is the all time high annual long term debt for Supernus Pharmaceuticals, Inc.?

Supernus Pharmaceuticals, Inc. all-time high annual long term debt is $423.98M

What is Supernus Pharmaceuticals, Inc. annual long term debt year-on-year change?

Over the past year, SUPN annual long term debt has changed by -$5.81M (-17.51%)

What is Supernus Pharmaceuticals, Inc. quarterly long term debt?

The current quarterly long term debt of SUPN is $24.38M

What is the all time high quarterly long term debt for Supernus Pharmaceuticals, Inc.?

Supernus Pharmaceuticals, Inc. all-time high quarterly long term debt is $444.06M

What is Supernus Pharmaceuticals, Inc. quarterly long term debt year-on-year change?

Over the past year, SUPN quarterly long term debt has changed by -$5.91M (-19.51%)
On this page